Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H L Harris

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Postgraduate Medical Journal|July 3, 2016
Single best answer question-writing tips for cliniciansJ L Walsh, B H L Harris, P E Smith
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 19, 2015
Gene Expression Signatures as Biomarkers of Tumour HypoxiaB H L Harris, A Barberis, C M L West, et al.
Clinical and Experimental Dermatology|December 29, 2017
Ring a ring o'roses, a patient with Kaposi's? Pazopanib, pazopanib, it might go away. Mediterranean (classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of standard therapyB H L Harris, J L Walsh, R Neciunaite, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Postgraduate Medical Journal|July 3, 2016
Single best answer question-writing tips for cliniciansJ L Walsh, B H L Harris, P E Smith
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 19, 2015
Gene Expression Signatures as Biomarkers of Tumour HypoxiaB H L Harris, A Barberis, C M L West, et al.
Clinical and Experimental Dermatology|December 29, 2017
Ring a ring o'roses, a patient with Kaposi's? Pazopanib, pazopanib, it might go away. Mediterranean (classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of standard therapyB H L Harris, J L Walsh, R Neciunaite, et al.
Pageof 1